GB9122051D0 - Medicines - Google Patents

Medicines

Info

Publication number
GB9122051D0
GB9122051D0 GB9122051A GB9122051A GB9122051D0 GB 9122051 D0 GB9122051 D0 GB 9122051D0 GB 9122051 A GB9122051 A GB 9122051A GB 9122051 A GB9122051 A GB 9122051A GB 9122051 D0 GB9122051 D0 GB 9122051D0
Authority
GB
United Kingdom
Prior art keywords
medicines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB9122051A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Nottingham
Original Assignee
University of Nottingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Nottingham filed Critical University of Nottingham
Priority to GB9122051A priority Critical patent/GB9122051D0/en
Publication of GB9122051D0 publication Critical patent/GB9122051D0/en
Priority to PCT/GB1992/001902 priority patent/WO1993007872A1/en
Pending legal-status Critical Current

Links

GB9122051A 1991-10-17 1991-10-17 Medicines Pending GB9122051D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB9122051A GB9122051D0 (en) 1991-10-17 1991-10-17 Medicines
PCT/GB1992/001902 WO1993007872A1 (en) 1991-10-17 1992-10-16 Lysosomal enzyme inhibitors for the treatment of neurodegenerative diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9122051A GB9122051D0 (en) 1991-10-17 1991-10-17 Medicines

Publications (1)

Publication Number Publication Date
GB9122051D0 true GB9122051D0 (en) 1991-11-27

Family

ID=10703088

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9122051A Pending GB9122051D0 (en) 1991-10-17 1991-10-17 Medicines

Country Status (2)

Country Link
GB (1) GB9122051D0 (en)
WO (1) WO1993007872A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW381025B (en) * 1993-08-05 2000-02-01 Hoffmann La Roche Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor
ZA945719B (en) * 1993-08-09 1996-02-01 Lilly Co Eli Identification and use of protease inhibitors
US6160106A (en) * 1993-10-12 2000-12-12 Yeda Research & Development Co., Ltd. Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins
IL107250A (en) * 1993-10-12 2001-08-08 Yeda Res & Dev Dna molecules involved in programmed cell death, proteins encoded thereby and methods and compositions using said dna molecules and proteins
DE10100053A1 (en) * 2001-01-02 2002-08-22 Keyneurotek Ag I G Use of enzyme inhibitors of dipeptidyl peptidase IV and aminopeptidase N and pharmaceutical preparations therefrom for the prevention and / or therapy of ischemia-related acute and chronic neurodegenerative processes and diseases
DE10337074A1 (en) 2003-08-12 2005-03-17 Keyneurotek Ag Use of the inhibitors of enzymes with activities of aminopeptidase N and / or dipeptidyl peptidase IV and pharmaceutical preparations thereof for the therapy and prevention of chronic neurodegenerative diseases
GB2568291A (en) * 2017-11-13 2019-05-15 Crisby Milita New use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100673A2 (en) * 1982-08-02 1984-02-15 The Research Foundation Of State University Of New York A method of enhancing neurofiber regrowth
US4789678A (en) * 1986-08-25 1988-12-06 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing α-alkyl-4-amino-3-quinolinemethanols and 1-(4-aralkylamino-3-quinolinyl)alkanones and related compounds
US4806537A (en) * 1987-04-16 1989-02-21 City Of Hope Use of amodiaquin and related compounds in treatment of nervous system degeneration
DK260987D0 (en) * 1987-05-22 1987-05-22 Nordisk Gentofte PROCEDURE FOR PREPARING A HUMAN PROTEIN AND THE DNA SEQUENCE FOR USE IN EXERCISING THE PROCEDURE
IL84252A (en) * 1987-10-23 1994-02-27 Yissum Res Dev Co Phospholipase inhibiting compositions
JPH03503843A (en) * 1988-04-15 1991-08-29 バイオジェン インコーポレイテッド Method for purifying phospholipase A2 and method for producing phospholipase A2-like polypeptide
JPH06503948A (en) * 1990-08-17 1994-05-12 ボストン・ユニヴァーシティー A protease that causes abnormal degradation of amyloid β-protein precursor

Also Published As

Publication number Publication date
WO1993007872A1 (en) 1993-04-29

Similar Documents

Publication Publication Date Title
CY2134B1 (en) Medicaments
AP9200403A0 (en) Medicaments
GB9115740D0 (en) Medicaments
GB9122051D0 (en) Medicines
GB9101221D0 (en) Pharmaceuticals
AP9200422A0 (en) Pharmaceuticals
GB2259019B (en) Soother
GB9108348D0 (en) Medicaments
GB9104650D0 (en) Medicaments
ZA927925B (en) Medicaments
GB9102377D0 (en) Medicine
GB9113163D0 (en) Medicinal
GB9111901D0 (en) Medicaments
GB9113377D0 (en) Medicaments
GB9122472D0 (en) Medicaments
SG74042A1 (en) Medicaments
GB9122475D0 (en) Medicaments
GB9123597D0 (en) Medicaments
GB9126027D0 (en) Medicaments
GB9126405D0 (en) Medicaments
GB9126444D0 (en) Medicaments
GB9116687D0 (en) Medicaments
GB9113787D0 (en) Medicaments
GB9113381D0 (en) Medicaments
GB9113379D0 (en) Medicaments